论文部分内容阅读
目的:分析术前及输血前检测传染性疾病标志物的重要性,包括乙肝两对半、丙型肝炎病毒抗体(抗-HCV)、梅毒螺旋体抗体(抗-TP)和人类免疫缺陷病毒抗体(抗-HIV1+2)检测。方法:采用酶联免疫吸附试验(ELISA)检测2 458例术前及输血前患者乙肝两对半、丙型肝炎病毒抗体(抗-HCV)、梅毒螺旋体抗体(抗-TP)和人类免疫缺陷病毒抗体(抗-HIV1+2)。结果:2 458例患者中,HBsAg阳性198例(8.06%),其中大三阳48例(1.95%),小三阳150例(6.1%)。HBsAb阳性936例(38.1%),抗-HCV21例(0.09%),抗-TP阳性10例(0.25%),抗-HIV阳性0例。结论:对术前及输血前患者常规进行感染性疾病标志物检测可区分患者是否因输血传播疾病,提高对输血风险的认识,增强自我保护意识,并起到早发现、早治疗的重要意义。
OBJECTIVE: To analyze the importance of preoperative and pretransfusion detection of infectious disease markers including hepatitis B two-and-a-half, hepatitis C virus (anti-HCV), Treponema pallidum (anti-TP) and human immunodeficiency virus antibodies Anti-HIV1 + 2) assay. Methods: Enzyme linked immunosorbent assay (ELISA) was used to detect the presence of hepatitis C virus (HCV), hepatitis C virus antibody (anti-HCV), syphilis antibody (anti-TP) and human immunodeficiency virus Antibody (anti-HIV1 + 2). Results: Of the 2 458 patients, HBsAg positive was found in 198 cases (8.06%), of which 48 cases (1.95%) were positive for Sanyang and 150 cases (6.1%) were positive for Sanyang. 936 cases (38.1%) were positive for HBsAb, 21 cases (0.09%) were anti-HCV, 10 cases (0.25%) were positive for anti-TP and 0 cases were positive for anti-HIV. CONCLUSIONS: Preoperative and pretransfusion patients routinely conduct infectious disease marker tests to distinguish patients from transfusion-transmitted diseases, improve their understanding of the risk of blood transfusion, enhance their awareness of self-protection, and play an important role in early detection and early treatment.